Hypothalamic-Pituitary-Adrenal Axis Study in Participants With Perennial Allergic Rhinitis
- Study Title
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Female, Maleergic Rhinitis (PAR)
- Teva Identifier
- BDP-AR-304
- ClinicalTrials.gov Identifier
- NCT01133626
- Study Status
- Completed
- Trial Condition(s)
- Perennial Female, Maleergic Rhinitis
- Interventions
- Drug: Placebo Nasal Aerosol | Drug: Prednisone capsules | Drug: Placebo Prednisone Capsules | Drug: Beclomethasone dipropionate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult
- Age Range
- 12 Years to 45 Years
- Trial Duration
- 06/01/2010 - 09/01/2010
- Phase
- Phase 3
